Utilizing New Technologies and Insulins for a Tighter Grip on PPG

Introduction/Overview

Major Mechanisms Linking Elevated PPG to Diabetes Complications

Recommended Targets for PPG

Diabetes Care Technologies: "Game Changers"

Patient Case Study

Smart Devices: CGM-Augmented Insulin Treatment

CGM From the Patient's Perspective

Optimizing Approaches to PPG Control

CSII: Insulin Pumps

Insulin Replacement Therapy Aims to Recreate the Normal Blood Insulin Profile

Ultra-Fast-Acting Insulins: Approaching a More Exact Physiologic Insulin Profile

Ultra-Fast-Acting Prandial Insulins

Trial of a Hybrid Closed-Loop Insulin Delivery System

The Challenge of Mimicking the Physiologic Response to Mealtime Glucose

BioChaperone® Lispro: Faster Insulin Kinetics Compared With Lispro (Injection)

Faster Aspart Pooled Analysis: Onset and Offset of Insulin Action

Patients With T1DM Who May Be Candidates for Ultra-Fast-Acting Insulins

Glucose-Monitoring With the FreeStyle Libre™ Device

Onset® 1: Study Design

Onset® 1: PPG (Test Meal)

Onset® 1: Faster-Acting Insulin Aspart Administered Postmeal

Onset® 4: Incidence of Hyperglycemia

Onset® 5: PPG Increment Results After a Standardized Meal Test

Scale of Self-Reported Psychological Complaints: Controls vs Patients With T1DM

Summary and Conclusions